APA (7th ed.) Citation

A, K., V, K., Z, B., G, Z., A, S., I, B., . . . A, K. (2026). The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma. Journal of clinical medicine, 15(9), . https://doi.org/10.3390/jcm15093492

Chicago Style (17th ed.) Citation

A, Karabekov, et al. "The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma." Journal of Clinical Medicine 15, no. 9 (2026). https://doi.org/10.3390/jcm15093492.

MLA (9th ed.) Citation

A, Karabekov, et al. "The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma." Journal of Clinical Medicine, vol. 15, no. 9, 2026, https://doi.org/10.3390/jcm15093492.